卓勝微(300782.SZ):公司部分射頻前端芯片產品可應用於汽車電子應用相關領域
格隆匯12月30日丨卓勝微(300782.SZ)在投資者互動平台表示,目前,公司部分射頻前端芯片產品可應用於汽車電子應用相關領域,在公司當前的市場及業務發展方向中佔比較低。 從戰略佈局上,公司在手機領域仍有較大的發展空間,中短期會優先圍繞移動智能終端市場進行佈局。未來公司將通過高端模組的佈局和推進,進一步提升品牌影響力和市場滲透率。長期而言,芯卓的能力逐步建設完善,將為公司拓展產品品類提供更多方面的可能性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.